Advertisement

Effect of hyaluronic acid on the regulation of inflammatory mediators in osteoarthritis of the temporomandibular joint: a systematic review

Published:February 19, 2017DOI:https://doi.org/10.1016/j.ijom.2017.01.014

      Abstract

      Osteoarthritis is one of the most frequent pathologies affecting the temporomandibular joint (TMJ). There is evidence that the use of intra-articular hyaluronic acid (HA) for the treatment of this disorder achieves positive effects through a reduction in inflammatory mediators. A systematic review of the available evidence regarding the regulation of inflammatory mediators when applying HA in osteoarthritis of the TMJ in humans was performed. The Web of Science, Embase, ScienceDirect, MEDLINE, Scopus, EBSCOhost, and LILACS databases, SciELO library, and search engine Trip Database were searched systematically. Two thousand eight hundred and sixty-three related articles were found, of which only two met the selection criteria (both were clinical trials and evidence level 2b for treatment studies). These two articles represented a population of 87 patients. Both articles reported that the application of HA had a positive effect on the regulation of inflammatory mediators; the mediators studied were those of the plasminogen activator system and levels of nitric oxide. The limited evidence available suggests that the application of HA regulates various inflammatory mediators in osteoarthritic processes in the TMJ. Nevertheless, further evidence in this regard is required, through the study of specific pathologies of the TMJ, complementing the assessment of clinical parameters with molecular studies, and generating good quality clinical studies with larger sample sizes.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kim C.H.
        • Lee B.J.
        • Yoon J.
        • Seo K.M.
        • Park J.H.
        • Lee J.W.
        • et al.
        Therapeutic effect of hyaluronic acid on experimental osteoarthrosis of ovine temporomandibular joint.
        J Vet Med Sci. 2001; 63: 1083-1089
        • Uchôa M.
        • Constantino G.
        Viscosupplementation.
        Rev Bras Ortop. 2012; 47: 160-164
        • Cledes G.
        • Felizardo R.
        • Foucart J.M.
        • Carpentier P.
        Validation of a chemical osteoarthritis model in rabbit temporomandibular joint: a compliment to biomechanical models.
        Int J Oral Maxillofac Surg. 2006; 35: 1026-1033
        • Okeson J.P.
        Diagnóstico de los trastornos temporomandibulares.
        in: Okeson J.P. Tratamiento de oclusión y afecciones temporomandibulares. sixth ed. Elsevier, Barcelona2008: 285-331
        • Güler N.
        • Kürkçü M.
        • Duygu G.
        • Çam B.
        Sodium iodoacetate induced osteoarthrosis model in rabbit temporomandibular joint: CT and histological study (Part I).
        Int J Oral Maxillofac Surg. 2011; 40: 1289-1295
        • Hirota W.
        Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4, 6-keto-prostaglandin F1alpha, prostaglandin F2alpha and interleukin-1beta in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint.
        Br J Oral Maxillofac Surg. 1998; 36: 35-38
        • Quinn J.H.
        • Bazar N.G.
        Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints.
        J Oral Maxillofac Surg. 1990; 48: 968-971
        • Shafer D.M.
        • Assael L.
        • White L.B.
        • Rossomando E.F.
        Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements.
        J Oral Maxillofac Surg. 1994; 54: 786-791
        • Fu K.
        • Ma X.
        • Zhang Z.
        • Chen W.
        Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders.
        J Oral Maxillofac Surg. 1995; 53: 424-426
        • Xinmin Y.
        • Jian H.
        Treatment of temporomandibular joint osteoarthritis with viscosupplementation and arthrocentesis on rabbit model.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: e35-e38
        • Guo H.
        • Fang W.
        • Li Y.
        • Ke J.
        • Deng M.
        • Meng Q.
        • et al.
        Up-regulation of proteoglycan 4 in temporomandibular osteoarthritic synovial cells by hyaluronic acid.
        J Oral Pathol Med. 2015; 44: 622-627
        • Brandt K.
        • Smith G.
        • Simon L.
        Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?.
        Arthritis Rheum. 2000; 43: 1192-1203
        • Welch V.
        • Petticrew M.
        • Tugwell P.
        • Moher D.
        • O’Neill J.
        • Waters E.
        • et al.
        PRISMA-Equity 2012 Extension: reporting guidelines for systematic reviews with a focus on health equity.
        PLoS Med. 2012; 9: e1001333
        • Manterola C.
        • Pineda V.
        • Vial M.
        • Losada H.
        • MINCIR Group
        What is the methodologic quality of human therapy studies in ISI surgical publications?.
        Ann Surg. 2006; 244: 827-832
        • Manterola C.
        • Vial M.
        • Pineda V.
        • Sanhueza A.
        Systematic review of literature with different types of designs.
        Int J Morphol. 2009; 27: 1179-1186
        • Moraga J.
        • Burgos M.E.
        • Manterola C.
        • Sanhueza A.
        • Cartes-Velásquez R.
        • Urrutia S.
        Reliability of MINCIR scale to evaluate methodological quality of therapy studies.
        Rev Chil Cir. 2013; 65: 222-227
        • Manterola C.
        • Cartes-Velasquez R.
        • Otzen T.
        Instructions for the use of MInCir scale to assess methodological quality in therapy studies.
        Int J Morphol. 2015; 33: 1463-1467
        • Tang Y.
        • Zhu G.
        • Hu L.
        • Zheng M.
        • Zhang J.
        • Shi Z.
        • et al.
        Effects of intra-articular administration of sodium hyaluronate on plasminogen activator system in temporomandibular joints with osteoarthritis.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109: 541-547
        • Guarda Nardini L.
        • Oliviero F.
        • Ramonda R.
        • Ferronato G.
        Influence of intra-articular injections of sodium hyaluronate on clinical features and synovial fluid nitric oxide levels of temporomandibular osteoarthritis.
        Reumatismo. 2004; 56: 272-277
        • Oxford Centre for Evidence-based Medicine (CEBM)
        Centre for Evidence Based Medicine—levels of evidence.
        2009, March (http://www.cebm.net/index.aspx?o=1025 [accessed 20.06.16])
        • Kopp S.
        • Carlsson G.E.
        • Haraldson T.
        • Wenneberg B.
        Long-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint arthritis.
        J Oral Maxillofac Surg. 1987; 45: 929-935
        • Alpaslan G.
        • Alpaslan C.
        Efficacy of TMJ arthrocentesis with and without injection of sodium hyaluronate.
        Int J Oral Maxillofac Surg. 1997; 26: 100
        • Del Rosso A.
        • Cinelli M.
        • Guiducci S.
        • Pignone A.
        • Fibbi G.
        • Margheri F.
        • et al.
        Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
        Rheumatology (Oxford). 2005; 44: 1255-1260
        • Busso N.
        • Peclat V.
        • So A.
        • Sappino A.P.
        Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.
        Ann Rheum Dis. 1997; 56: 550-557
        • Sakamaki H.
        • Ogura N.
        • Kujiraoka H.
        • Akiba M.
        • Abiko Y.
        • Nagura H.
        Activities of plasminogen activator, plasmin and kallikrein in synovial fluid from patients with temporomandibular joint disorders.
        Int J Oral Maxillofac Surg. 2001; 30: 323-328
        • Zhu G.
        • Tang Y.
        • Liang X.
        • Zheng M.
        • Yang J.
        • Zhou H.
        • et al.
        Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes.
        Osteoarthritis Cartilage. 2009; 17: 1494-1502
        • Takahashi T.
        • Kondoh T.
        • Kamei K.
        • Seki H.
        • Fukuda M.
        • Nagai H.
        • et al.
        Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82: 505-509
        • Stefanovic R.M.
        • Stadler J.
        • Georgescu H.I.
        • Evans C.H.
        Nitric oxide synthesis and its regulation by rabbit synoviocytes.
        J Rheumatol. 1994; 21: 1892-1898
        • Alpaslan C.
        • Bilgihan A.
        • Alpaslan G.
        • Giiner B.
        • Yis M.O.
        • Erbas D.
        Effect of arthrocentesis and sodium hyaluronate injection on nitrite, nitrate, and thiobarbituric acid-reactive substance levels in the synovial fluid.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89: 686-690
        • Stichtenoth D.O.
        • Frölich J.C.
        Nitric oxide and inflammatory joint diseases.
        Br J Rheumatol. 1998; 37: 246-257